All In Biotech

Drug Trial Radar · NCT06683352

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

A PHASE 1/2, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF COMBINED VACCINE CANDIDATES AGAINST INFLUENZA AND COVID-19 IN HEALTHY INDIVIDUALS

Last checked: Nov 20, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,353 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,353

Actual

Start

Nov 11, 2024

Primary completion

Jul 15, 2025

Study completion Jul 15, 2025

Sponsor

Lead sponsor
BioNTech SEIndustry
Sponsor type
Industry
Collaborators
Pfizer
First posted
Nov 12, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is to learn about flu and COVID vaccines, either alone or when mixed together. Healthy people aged 18 or older can join. Participants will get one shot in each arm, either a flu or COVID vaccine, alone or mixed. The study lasts about 6 months, and participants need to visit the research site at least 3 times.

Conditions

  • Influenza,Human
  • COVID-19

Interventions

  • Investigational Influenza VaccineBiological

    Investigational Influenza Vaccine

  • COVID-19 VaccineBiological

    Pfizer-BioNTech COVID-19 Vaccine

  • Investigational Influenza/COVID-19 VaccineCombination product

    Combined investigational influenza and Pfizer-BioNTech COVID-19 Vaccine

  • Licensed Influenza Vaccine 1Biological

    Licensed Influenza Vaccine 1

  • Licensed Influenza Vaccine 2Biological

    Licensed Influenza Vaccine 2

  • PlaceboOther

    Saline

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cohort 1: Percentage of Participants With Any Local Reactions for up to 7 Days Following VaccinationTime frame: From Day 1 through Day 7 after Vaccination [Vaccination on Day 1]
  2. Cohort 2: Percentage of Participants With Any Local Reactions for up to 7 Days Following VaccinationTime frame: From Day 1 through Day 7 after Vaccination [Vaccination on Day 1]
  3. Cohort 1: Percentage of Participants With Any Systemic Events for up to 7 Days Following VaccinationTime frame: From Day 1 through Day 7 after Vaccination [Vaccination on Day 1]
  4. Cohort 2: Percentage of Participants With Any Systemic Events for up to 7 Days Following VaccinationTime frame: From Day 1 through Day 7 after Vaccination [Vaccination on Day 1]
  5. Cohort 1: Percentage of Participants Reporting Adverse Events (AEs) From Vaccination Through 1 Month After VaccinationTime frame: From Vaccination on Day 1 through 1 month after Vaccination [Vaccination on Day 1]
  6. Cohort 2: Percentage of Participants Reporting AEs From Vaccination Through 1 Month After VaccinationTime frame: From Vaccination on Day 1 through 1 month after Vaccination [Vaccination on Day 1]
  7. Cohort 1: Percentage of Participants Reporting SAEs From Vaccination Through 6 Months After VaccinationTime frame: From Vaccination on Day 1 through 6 Months after Vaccination [Vaccination on Day 1]
  8. Cohort 2: Percentage of Participants Reporting SAEs From Vaccination Through 6 Months After VaccinationTime frame: From Vaccination on Day 1 through 6 Months after Vaccination [Vaccination on Day 1]

Locations

22 sites in 1 country. Site status is shown where the registry gives one.

  • Orange County Research Center

    Lake Forest, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • Diablo Clinical Research, Inc.

    Walnut Creek, California

  • Clinical Research Consulting

    Milford, Connecticut

  • Indago Research & Health Center, Inc

    Hialeah, Florida

  • Miami Dade Medical Research Institute, LLC

    Miami, Florida

  • Palm Springs Community Health Center

    Miami Lakes, Florida

  • Headlands Research Orlando

    Orlando, Florida

  • Clinical Research Atlanta

    Stockbridge, Georgia

  • East-West Medical Research Institute

    Honolulu, Hawaii

  • Clinical Research Professionals

    Chesterfield, Missouri

  • Bio-Kinetic Clinical Applications, LLC dba QPS-MO

    Springfield, Missouri

  • Bio-Kinetic Clinical Applications, LLC dba QPS-MO-Screening and Recruitment Center

    Springfield, Missouri

  • Velocity Clinical Research, Omaha

    Omaha, Nebraska

  • Las Vegas Clinical Trials

    Las Vegas, Nevada

  • ActivMed Practices & Research, LLC.

    Portsmouth, New Hampshire

  • DM Clinical Research- Cyfair

    Houston, Texas

  • SMS Clinical Research

    Mesquite, Texas

  • Dynamed Clinical Research, LP d/b/a DM Clinical Research

    Tomball, Texas

  • J. Lewis Research, Inc. / Foothill Family Clinic

    Salt Lake City, Utah

  • J. Lewis Research, Inc. / Foothill Family Clinic South

    Salt Lake City, Utah

  • Charlottesville Medical Research

    Charlottesville, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.